BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33078998)

  • 1. Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone.
    Kosmin M; Padhani AR; Gogbashian A; Woolf D; Ah-See ML; Ostler P; Sutherland S; Miles D; Noble J; Koh DM; Marshall A; Dunn J; Makris A
    Radiology; 2020 Dec; 297(3):622-629. PubMed ID: 33078998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer.
    Haraldsen A; Bluhme H; Røhl L; Pedersen EM; Jensen AB; Hansen EB; Nellemann H; Rasmussen F; Morsing A
    Clin Physiol Funct Imaging; 2016 Jan; 36(1):40-6. PubMed ID: 25257661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy.
    Takenaka D; Ohno Y; Matsumoto K; Aoyama N; Onishi Y; Koyama H; Nogami M; Yoshikawa T; Matsumoto S; Sugimura K
    J Magn Reson Imaging; 2009 Aug; 30(2):298-308. PubMed ID: 19629984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer.
    Kosmin M; Makris A; Joshi PV; Ah-See ML; Woolf D; Padhani AR
    Eur J Cancer; 2017 May; 77():109-116. PubMed ID: 28390297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
    Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
    Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Study Comparing
    Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
    J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the addition of whole-body MRI to routine imaging influence real-world treatment decisions in metastatic breast cancer?
    Bhaludin BN; Tunariu N; Senthivel N; Babiker A; Soneji ND; Hujairi N; Sharma B; McGrath SE; Okines AF; Ring AE; Messiou C; Downey K; Koh DM
    Cancer Imaging; 2022 Jun; 22(1):26. PubMed ID: 35672838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of whole-body diffusion-weighted MRI in detecting bone metastasis.
    Del Vescovo R; Frauenfelder G; Giurazza F; Piccolo CL; Cazzato RL; Grasso RF; Schena E; Zobel BB
    Radiol Med; 2014 Oct; 119(10):758-66. PubMed ID: 24638912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.
    Sohaib SA; Cook G; Allen SD; Hughes M; Eisen T; Gore M
    Br J Radiol; 2009 Aug; 82(980):632-9. PubMed ID: 19221182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
    Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
    Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma.
    Mosavi F; Johansson S; Sandberg DT; Turesson I; Sörensen J; Ahlström H
    AJR Am J Roentgenol; 2012 Nov; 199(5):1114-20. PubMed ID: 23096187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases.
    Balliu E; Boada M; Peláez I; Vilanova JC; Barceló-Vidal C; Rubio A; Galofré P; Castro A; Pedraza S
    Clin Radiol; 2010 Dec; 65(12):989-96. PubMed ID: 21070903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer.
    Zugni F; Ruju F; Pricolo P; Alessi S; Iorfida M; Colleoni MA; Bellomi M; Petralia G
    PLoS One; 2018; 13(10):e0205251. PubMed ID: 30312335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Accuracy of Planar and Evolution SPECT/CT Bone Imaging in Differentiating Benign from Metastatic Bone Lesions.
    Teyateeti A; Tocharoenchai C; Muangsomboon K; Komoltri C; Pusuwan P
    J Med Assoc Thai; 2017 Jan; 100(1):100-10. PubMed ID: 29911774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral parametric segmentation of contrast-enhanced dual-energy CT to detect bone metastasis: feasibility sensitivity study using whole-body bone scintigraphy.
    Lee YH; Kim S; Lim D; Suh JS; Song HT
    Acta Radiol; 2015 Apr; 56(4):458-64. PubMed ID: 24714734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion-weighted images.
    Nakanishi K; Kobayashi M; Nakaguchi K; Kyakuno M; Hashimoto N; Onishi H; Maeda N; Nakata S; Kuwabara M; Murakami T; Nakamura H
    Magn Reson Med Sci; 2007; 6(3):147-55. PubMed ID: 18037795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of bone metastases from breast cancer by bone scintigraphy and positron emission tomography/computed tomography imaging.
    Pires AO; Borges US; Lopes-Costa PV; Gebrim LH; da Silva BB
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():138-41. PubMed ID: 25037283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of a computer-aided diagnosis system for whole-body bone scintigraphy to detect bone metastasis in breast cancer patients.
    Urano M; Maki Y; Nishikawa H; Kawai T; Shiraki N; Shibamoto Y
    Ann Nucl Med; 2017 Jan; 31(1):40-45. PubMed ID: 27686468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.